Moderna shares surge after vaccine maker’s posts shallower-than-expected loss By Investing.com
Investing.com – Moderna (NASDAQ:) has reported a shallower-than-anticipated loss in the third quarter and announced changes at its leadership team, as the drugmaker looks to address issues stemming from fading sales of its COVID-19 vaccine since a pandemic-era boom in demand. In the three months ended on Sept. 30, total revenue rose by 1.7% versus the…